Results

Total Results: over 10,000 records

Showing results for "cancer".
Users also searched for: colon cancer screening

1. Cancer-Drugs-Utilization Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
   January 01, 2011 - malignancies and/ or head and neck cancer (an off- label use). … indicative of its use in malignant neoplasms of the genitourinary tract (e.g., bladder cancer). … both malignant neoplasm of pancreas (157) and esophagus (150), appeared in 23 percent of beneficiaries … Sixty-seven percent of beneficiaries with an imatinib order had a prior diagnosis of malignant neoplasm … Denileukin was accompanied by a prior diagnosis of malignant neoplasm of lymphatic and hematopoietic

2. Cancer-Drugs-Utilization Research (pdf file)
   effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
   January 01, 2011 - malignancies and/ or head and neck cancer (an off- label use). … indicative of its use in malignant neoplasms of the genitourinary tract (e.g., bladder cancer). … both malignant neoplasm of pancreas (157) and esophagus (150), appeared in 23 percent of beneficiaries … Sixty-seven percent of beneficiaries with an imatinib order had a prior diagnosis of malignant neoplasm … Denileukin was accompanied by a prior diagnosis of malignant neoplasm of lymphatic and hematopoietic

3. Fielding the CAHPS Cancer Care Survey (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/fielding-cancer-53.pdf
   July 14, 2017 - The person has a primary ICD-10 CM diagnosis of any malignant neoplasms (C00-D09.9, excluding D05- carcinoma … C53.0 Malignant neoplasm of endocervix C53.1 Malignant neoplasm of exocervix C53.8 Malignant neoplasm … Malignant neoplasm of cecum C18.1 Malignant neoplasm of appendix C18.2 Malignant neoplasm of ascending … 58957* Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy … (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed 58958* Resection (tumor

4. Clinical Classifications for Health Policy Research: Hospital Inpatient Statistics, 1995
   hcup-us.ahrq.gov/reports/natstats/his95/appca.htm
   February 11, 2011 - malignancies 42 - 2.12.1 Secondary malignancy of lymph … neoplasm without 43 - specification of site 2.14 Neoplasms … neoplasms 46 47 - 2.16.1 Benign neoplasm of uterus … 2.16.2.1 Benign neoplasm of ovary - 220 2.16.2.2 … Benign neoplasm of colon - 2113 2114 V1272 2.16.2.3 Benign neoplasm

5. Trends in Hysterectomies and Oophorectomies in Hospital Inpatient and Ambulatory Settings, 2005-2013 #214
   hcup-us.ahrq.gov/reports/statbriefs/sb214-Hysterectomy-Oophorectomy-Trends.jsp
   November 01, 2016 - Hysterectomy alone: female genital cancer, 5%; benign neoplasms, 50%; other gynecological and maternal … Oophorectomy alone: female genital cancer, 5%; benign neoplasms, 28%; other gynecological and maternal … Hysterectomy and oophorectomy in combination: female genital cancer, 21%; benign neoplasms, 41%; other … - Benign neoplasm of ovary 221.0 - Benign neoplasm of fallopian tube and uterine ligaments 221.1 … - Benign neoplasm of vagina 221.2 - Benign neoplasm of vulva 221.8 - Benign neoplasm of other specified

6. Fielding the CAHPS Cancer Care Survey (pdf file)
   www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/fielding-cancer-53.pdf
   July 14, 2017 - The person has a primary ICD-10 CM diagnosis of any malignant neoplasms (C00-D09.9, excluding D05- carcinoma … C53.0 Malignant neoplasm of endocervix C53.1 Malignant neoplasm of exocervix C53.8 Malignant neoplasm … Malignant neoplasm of cecum C18.1 Malignant neoplasm of appendix C18.2 Malignant neoplasm of ascending … 58957* Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy … (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed 58958* Resection (tumor

7. Fielding the CAHPS Cancer Care Survey (pdf file)
   ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/fielding-cancer-53.pdf
   July 14, 2017 - The person has a primary ICD-10 CM diagnosis of any malignant neoplasms (C00-D09.9, excluding D05- carcinoma … C53.0 Malignant neoplasm of endocervix C53.1 Malignant neoplasm of exocervix C53.8 Malignant neoplasm … Malignant neoplasm of cecum C18.1 Malignant neoplasm of appendix C18.2 Malignant neoplasm of ascending … 58957* Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy … (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed 58958* Resection (tumor

8. Archived: Final Evidence Review: Ovarian Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review78/ovarian-cancer-screening-2012
   April 15, 2012 - has the highest mortality rate of all gynecologic malignancies, and was the fifth leading cause of cancer … Ovarian cancer is a frequently fatal malignancy; in 2008, there were an estimated 15,520 deaths in the … The positive predictive value (PPV) of TVU was 1.6 percent for any neoplasm, and 1.0 percent if tumors … (15 invasive cancer cases and one tumor of low malignant potential). … or benign neoplasms 10 .

9. Screening for Ovarian Cancer: Evidence Update for the USPTF Reaffirmation Recommendation Statement (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/fNXdu3HGvWE-ovsuhNeANW
   April 01, 2012 - Abstract Background: Ovarian cancer has the highest mortality rate of all gynecologic malignancies … leading cause of cancer death. 1 Ovarian cancer is a frequently fatal malignancy; in 2008, there … The positive predictive value (PPV) of TVU was 1.6 percent for any neoplasm, and 1.0 percent if tumors … (15 invasive cancer cases and one tumor of low malignant potential). … or benign neoplasms. 10 The main gap in our knowledge that is key to making the case for screening

10. Hospital Inpatient Statistics, 1996
    hcup-us.ahrq.gov/reports/natstats/his96/table1a.htm
    January 01, 1996 - $19,298 $6,477 $11,726 $21,246 7.2 7.4 51.4 51.8 2.12 Secondary malignancies … 0.30 $18,747 $6,525 $12,165 $22,263 8.7 13.2 36.9 65.6 2.13 Malignant … $11,640 3.7 0.3 11.8 48.1 2.16.1 Benign neoplasm of uterus [46.] … $9,017 $15,389 4.6 0.6 29.2 54.4 2.16.2.1 Benign neoplasm … 5.9 0.7 48.5 69.4 2.16.2.3 Benign neoplasm of the thyroid 12,419

11. Hospital Inpatient Statistics, 1996
    hcup-us.ahrq.gov/reports/natstats/his95/table1a.htm
    January 01, 1996 - $19,298 $6,477 $11,726 $21,246 7.2 7.4 51.4 51.8 2.12 Secondary malignancies … 0.30 $18,747 $6,525 $12,165 $22,263 8.7 13.2 36.9 65.6 2.13 Malignant … $11,640 3.7 0.3 11.8 48.1 2.16.1 Benign neoplasm of uterus [46.] … $9,017 $15,389 4.6 0.6 29.2 54.4 2.16.2.1 Benign neoplasm … 5.9 0.7 48.5 69.4 2.16.2.3 Benign neoplasm of the thyroid 12,419

12. Trends in Hysterectomies and Oophorectomies in Hospital Inpatient and Ambulatory Settings, 2005-2013 (pdf file)
    hcup-us.ahrq.gov/reports/statbriefs/sb214-Hysterectomy-Oophorectomy-Trends.pdf
    January 01, 2016 - – Malignant neoplasm of exocervix • 180.8 – Malignant neoplasm of other specified sites of cervix … – Malignant neoplasm of placenta • 182.0 – Malignant neoplasm of corpus uteri, except isthmus • … – Malignant neoplasm of vagina • 184.1 – Malignant neoplasm of labia majora • 184.2 – Malignant neoplasm … – Benign neoplasm of ovary • 221.0 – Benign neoplasm of fallopian tube and uterine ligaments • 221.1 … – Benign neoplasm of vagina • 221.2 – Benign neoplasm of vulva • 221.8 – Benign neoplasm of other

13. Appendixes: Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendices.pdf
    May 22, 2024 - site cancers":ti,ab OR "multisite neoplasm":ti,ab OR "multi site neoplasm":ti,ab OR "multisite neoplasms … site cancers":ti,ab OR "multisite neoplasm":ti,ab OR "multi site neoplasm":ti,ab OR "multisite neoplasms … Detection and identification of hematologic malignancies and solid tumors by an electrochemical technique … Personalized cancer monitoring assay for the detection of ctDNA in patients with solid tumors. … Neoplasia. 2023 Dec;46:100941. doi: 10.1016/j.neo.2023.100941. PMID: 37918207. 7.

14. DXCCSR-vs-Beta-CCS-Comparison (pdf file)
    hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-vs-Beta-CCS-Comparison.pdf
    January 01, 2020 - NEO070 Secondary malignancies 6 6 0 43 Malignant neoplasm without specification of site NEO071 Malignant … neoplasm, unspecified 10 9 1 47 Other and unspecified benign neoplasm NEO073 Benign neoplasms 9 1 … NEO070 – Secondary malignancies 43 Malignant neoplasm without specification of site 3 NEO066 – Malignant … neoplasm of uterus 1 NEO073 – Benign neoplasms 47 Other and unspecified benign neoplasm 3 NEO073 – … Benign neoplasms 48 Thyroid disorders 3 END001 – Thyroid disorders 49 Diabetes mellitus without complication

15. 3.a-1 Sample Programming Criteria for Initial Electronic Record Review | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/final-reports/crctoolkit/crctool3a1.html
    April 01, 2018 - Tracking and Improving Screening for Colorectal Cancer Intervention 3.a-1 Sample Programming Criteria … Previous Page Next Page Table of Contents Tracking and Improving Screening for Colorectal Cancer … ICD-9 Codes for Excluded Diagnoses Diagnosis ICD-9 Codes Malignant neoplasms 153.0- … 154.8 Benign neoplasms 211.3-211.4 Colorectal and intestinal neoplasms 159, 197.5, 197.8

16. Blood-based Tests for Multiple Cancer Screening: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/cell-free-dna/protocol
    July 22, 2024 - suggest these are biologically different tumors. 26 Earlier diagnosis of tumors with certain molecular … Neoplasms"[Mesh] OR "Uterine Cervical Neoplasms"[Mesh] 2,585,739 #3 "adrenal gland neoplasm"[title] … cancers"[tiab] OR "multisite neoplasm"[tiab:~3] OR "multi-site neoplasm"[tiab:~3] OR "multisite neoplasms … cancers"[tiab] OR "multisite neoplasm"[tiab:~3] OR "multi-site neoplasm"[tiab:~3] OR "multisite neoplasms … tiab] OR "multi-site cancer"[tiab] OR "multi-site cancers"[tiab] OR "multisite neoplasm"[tiab:~3] OR

17. Disparities and Barriers for Pediatric Cancer Survivorship Care | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/pediatric-cancer-survivorship/protocol
    June 24, 2020 - kidney failure, liver disease, osteopenia and osteoporosis, neurocognitive deficits, and secondary malignancies … for CCS is critical to minimize and alleviate disparities due to the adverse sequelae of their prior malignancy … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan

18. Screening for Ovarian Cancer: Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/cTa7Hs56-yj4kCr7yXLdRm
    July 01, 1994 - - ian tumors defines various tumor types on the basis of Ann Intern Med. 1994;121:124-132. … Common epithelial tumors account for 90% of all ovarian malignancies (8). … A subgroup of epi- thelial neoplasms, termed "borderline tumors" or "cyst- adenomas of low malignant … Sonographic patterns of ovarian tumors: prediction of malignancy. … cancers.

19. HCUP Statistical Brief #37: Pediatric Hospital Stays for Cancer, 2005 (pdf file)
    hcup-us.ahrq.gov/reports/statbriefs/sb37.pdf
    September 01, 2007 - http://plan2004.cancer.gov/public/survivor.htm 4The term “brain tumors” refers to all cancers of the … Characteristics of two common pediatric cancers: leukemias and brain tumors Table 3 provides detailed … Among children and adolescents, the most common cancer stays were for leukemias and brain tumors. … primary 3,000 11.6 $33,900 $102.6 million 4.2 47.7% 10.3% * Secondary malignancies 2,200 7.2 … Note: Miscellaneous cancers that are grouped as “other benign neoplasms” (CCS category 47) are excluded

20. Archived: Routine Vitamin Supplementation to Prevent Cancer: Update of the Evidence from Randomized Controlled Trials 1999-2002*: Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/routine-vitamin-supplementation-to-prevent-cancer-update-of-the-evidence-from-randomized-controlled-trials-19992002/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
    June 15, 2003 - Incidence of basal cell carcinoma and squamous cell carcinoma and number of tumors among subjects with … Cases of malignant neoplasms excluding nonmelanoma skin cancer; lung cancer; malignant cancer mortality … Any malignant neoplasm except non-melanoma skin, primary-lung cancer. … Primary-lung cancer incidence and mortality; secondary-cancers other than lung cancer. 29,133 subjects … Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms